公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2024 | Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence | Qin, Xian-Yang; Shirakami, Yohei; Honda, Masao; Shiou-Hwei Yeh ; Numata, Kazushi; Lai, Ya-Yun; Li, Chiao-Ling; Wei, Feifei; Xu, Yali; Imai, Kenji; Takai, Koji; Chuma, Makoto; Komatsu, Nagisa; Furutani, Yutaka; Gailhouste, Luc; Aikata, Hiroshi; Chayama, Kazuaki; Enomoto, Masaru; Tateishi, Ryosuke; Kawaguchi, Kazunori; Yamashita, Tatsuya; Kaneko, Shuichi; Nagaoka, Katsuya; Tanaka, Motohiko; Sasaki, Yutaka; Tanaka, Yasuhito; Baba, Hideo; Miura, Kouichi; Ochi, Sae; Masaki, Takahiro; Kojima, Soichi; Matsuura, Tomokazu; Shimizu, Masahito; PEI-JER CHEN ; Moriwaki, Hisataka; Suzuki, Harukazu | International journal of cancer | |||
2007 | Somatic mutations at the trinucleotide repeats of androgen receptor gene in male hepatocellular carcinoma | Shiou-Hwei Yeh ; Chiu C.-M.; CHI-LING CHEN ; Lu S.-F.; Hsu H.-C.; DING-SHINN CHEN ; PEI-JER CHEN | International Journal of Cancer | 22 | 17 | |
2005 | Somatic mutations in epidermal growth factor receptor underlying complete responsiveness to gefitinib in a Taiwanese female patient with metastatic adenocarcinoma of lung | KUN-HUEI YEH ; Shiou-Hwei Yeh ; Wan J.-P.; Ying-Chun Shen ; ANN-LII CHENG | Anti-Cancer Drugs | 4 | 3 | |
2015 | Sorafenib Action in Hepatitis B Virus X-Activated Oncogenic Androgen Pathway in Liver Through SHP-1 | Wang S.-H.; Shiou-Hwei Yeh ; Shiau C.-W.; Chen K.-F.; Lin W.-H.; Tsai T.-F.; Teng Y.-C.; DING-SHINN CHEN ; PEI-JER CHEN | Journal of the National Cancer Institute | 20 | 14 | |
2019 | Specific diacylglycerols generated by hepatic lipogenesis stimulate the oncogenic androgen receptor activity in male hepatocytes | Cheng Y.-W.; Chen K.-W.; Kuo H.-C.; CHING-HUA KUO ; Lin W.-H.; PEI-JER CHEN ; Shiou-Hwei Yeh | International Journal of Obesity | 7 | 4 | |
2023 | Synergistic efficacy of telomerase-specific oncolytic adenoviral therapy and histone deacetylase inhibition in human hepatocellular carcinoma | ZHONG-ZHE LIN ; Hu, Mickey C-T; CHIUN HSU ; YAO-MING WU ; YEN-SHEN LU ; Ho, Ja-An Annie; Shiou-Hwei Yeh ; PEI-JER CHEN ; ANN-LII CHENG | Cancer letters | 1 | 1 | |
2013 | Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice | Lin W.-H.; Shiou-Hwei Yeh ; Yang W.-J.; KUN-HUEI YEH ; Fujiwara T.; Nii A.; Chang S.S.-C.; PEI-JER CHEN | International Journal of Cancer | 20 | 19 | |
2006 | Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan | CHUN-JEN LIU ; SHYH-CHYI LO ; JIA-HORNG KAO ; Tseng P.-T.; Lai M.-Y.; YEN-HSUAN NI ; Shiou-Hwei Yeh ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Hepatology | 98 | 88 | |
2021 | Unique features of hepatitis b virus-related hepatocellular carcinoma in pathogenesis and clinical significance | Wang S.-H.; Shiou-Hwei Yeh ; PEI-JER CHEN | Cancers | 11 | 11 | |
2008 | Viral hepatocarcinogenesis: From infection to cancer | Tan A.; Shiou-Hwei Yeh ; CHUN-JEN LIU ; Cheung C.; PEI-JER CHEN | Liver International | 102 | 84 |